Evolent Health's GAAP loss for 6 months of 2020 was $282,273 million, up 3.5 times from $80,549 million the previous year. Revenue increased by 24.7% to $485,917 million from $389,715 million a year earlier.
Evolent Health's GAAP loss for 6 months of 2020 was $282,273 million, up 3.5 times from $80,549 million the previous year. Revenue increased by 24.7% to $485,917 million from $389,715 million a year earlier. 
ir.evolenthealth.com
English (US) 